207 related articles for article (PubMed ID: 15077166)
1. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.
Tong X; O'Kelly J; Xie D; Mori A; Lemp N; McKenna R; Miller CW; Koeffler HP
Oncogene; 2004 Jun; 23(28):4847-55. PubMed ID: 15077166
[TBL] [Abstract][Full Text] [Related]
2. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
Tong X; Xie D; O'Kelly J; Miller CW; Muller-Tidow C; Koeffler HP
J Biol Chem; 2001 Dec; 276(50):47709-14. PubMed ID: 11598125
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells.
Chien W; Yin D; Gui D; Mori A; Frank JM; Said J; Kusuanco D; Marchevsky A; McKenna R; Koeffler HP
Mol Cancer Res; 2006 Aug; 4(8):591-8. PubMed ID: 16877704
[TBL] [Abstract][Full Text] [Related]
4. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
5. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
[TBL] [Abstract][Full Text] [Related]
6. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
Vellon L; Menendez JA; Lupu R
Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
[TBL] [Abstract][Full Text] [Related]
9. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung.
Shu W; Guttentag S; Wang Z; Andl T; Ballard P; Lu MM; Piccolo S; Birchmeier W; Whitsett JA; Millar SE; Morrisey EE
Dev Biol; 2005 Jul; 283(1):226-39. PubMed ID: 15907834
[TBL] [Abstract][Full Text] [Related]
10. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
11. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells.
Jaiswal AS; Marlow BP; Gupta N; Narayan S
Oncogene; 2002 Dec; 21(55):8414-27. PubMed ID: 12466962
[TBL] [Abstract][Full Text] [Related]
12. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
13. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
Xie Z; Zeng X; Waldman T; Glazer RI
Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
15. Cyr61 suppresses growth of human endometrial cancer cells.
Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
[TBL] [Abstract][Full Text] [Related]
18. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
[TBL] [Abstract][Full Text] [Related]
19. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
[TBL] [Abstract][Full Text] [Related]
20. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
